ArticleFrontiers in endocrinology2025
Comprehensive characterization of 21-hydroxylase deficiency in a Chinese pediatric cohort: phenotype, steroid profiles and genetics.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the clinical, steroid hormones and genetic characteristics of Chinese children with 21-hydroxylase deficiency (21OHD). Methods: This retrospective study included 115 children with 21OHD. Clinical data, steroid hormone levels, and genetic information were collected for overall and subgroup analyses. Clinical and steroid hormone characteristics were compared across clinical phenotypes and by sex. Within the salt-wasting (SW) group, characteristics were also compared between newborn screening (NBS)-diagnosed and clinically diagnosed patients. The relationship between Prader scores and both clinical phenotype and steroid hormone levels was analyzed, and the genotype-phenotype correlation, variation frequency and CAH-X CH-1 incidence were calculated. Results: The cohort comprised 76 (66.09%) SW, 27 (23.48%) simple virilizing (SV), and 12 (10.43%) non-classic (NC) patients. The overall levels of adrenocorticotropic hormone (ACTH), 17-hydroxyprogesterone(17OHP), and progesterone (P) levels were significantly elevated in SW and SV compared to NC patients. Girls with Prader scores ≥1 had higher hormone levels than those with normal external genitalia. Virilization was more severe in SW than SV girls. NBS significantly reduced the diagnostic delay for SW infants. Functional assays and SpliceAI prediction confirmed that a novel splice variant (c.203-1G>A) induces exon 2 skipping. We also report the first instance of cis double mutations (E3del8bp and p.V282L) on a single allele in two brothers. The allele frequency of p.V282L (5.16%) and CAH-X CH-1 incidence (11.32%) were higher than previously reported. Conclusion: This study expands the 21OHD mutational spectrum with two novel findings: a pathogenic splice-site variant (c.203-1G>A) and cis double mutations on a single allele. We demonstrate phenotype-specific differences in virilization and steroid hormones, underscoring the value of Prader scoring. NBS facilitated earlier diagnosis in SW patients, supporting its nationwide implementation in China. Our findings illustrate a distinct genetic architecture for 21OHD in the Chinese population, correlating with increased detection of NC cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.